Full Papers
doi.org/10.1002/ejoc.202100205
(400 MHz, CDCl3) δ1H 8.51–8.54 (m, 1H, ArH), 8.27a (s, 1H, CH=N),
(376 MHz, CDCl3 ) δ19F À 66.7 (s, 3F); GC-MS (m/z (relative %)): tR =
2.3 min; m/z 258 (100, M.+), 199 (36), 131 (50), 104 (49), 86 (38), 77
(51).
1
2
3
4
5
6
7
8
9
7.50–7.86 (m, 3H, ArH), 7.44–7.49 (m, 3H, ArH), 3.91–3.94 (apparent
t, 4H, CH2O), 3.27–3.29, (apparent t, 4H, CH2O); 13C NMR (400 MHz,
CDCl3) δ13C 135.5, 134.1, 131.6, 130.9, 129, 128.9, 126.6, 125.9, 125.7,
125.5, 124, 66.7, 52.2.
(E)-2,2,2-trifluoro-N-morpholino-1-(4-nitrophenyl)ethan-1-imine
(2b).[25,26,37] The compound 2b was prepared according to general
procedure using 1b (116 mg, 0.5 mmol) and the crude product was
purified by column chromatography to afford 2b as a yellow solid.
(E)-1-(furan-2-yl)-N-morpholinomethanimine (1k).[25] The title com-
pound was prepared according to the general procedure 1 using 2-
furfural (353 mg, 1.96 mmol) and 4-aminomorpholine (401 mg,
3.92 mmol). Yield: 230 mg (1.28 mmol; 65%); 1H NMR (400 MHz,
CDCl3) δ1H 7.44 (s, 1H, CH=N), 7.40 (s, 1H, ArH), 6.39–6.45 (apparent
t, 2H, ArH), 3.84–3.86 (apparent t, 4H, CH2O), 3.12–3.14, (apparent t,
4H, CH2O); 13C NMR (100 MHz, CDCl3) δ13C 151.4, 143, 126.9, 111.6,
109.4, 66.5, 51.9.
1
Yield: 105 mg (0.35 mmol; 70%); H NMR (400 MHz, CDCl3) δ1H 8.25
(d, 2H, J=8 Hz), 7.6 (d, 2H, J=8 Hz), 3.6-3.63 (apparent t, 4H, CH2O),
2.98–3.01 (apparent t, 4H, CH2N); 13C NMR (100 MHz, CDCl3) δ13C
1
148.6, 138.3, 132.6 (q, 2JC-F =34 Hz), 130, 124.2, 122.5 (q, JC-F
=
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
271 Hz), 66.1, 54.6 ; 19F NMR (376 MHz, CDCl3 ) δ19F À 66.1(s, 3F); GC-
MS (m/z (relative %)): tR =4.2 min; m/z 303 (M.+), 288 (13), 244 (21),
198 (35), 176 (31), 103 (38), 85 (36), 56 (100).
(E)-1-(2,6-dichlorophenyl)-N-morpholinomethanimine (1l).[26] The
compound 1l was prepared according to the general procedure
using 2,6-dichlorobenzaldehyde (417 mg, 1.61 mmol) and 4-amino-
morpholine (329 mg, 3.22 mmol). Yield: 351 mg (1.36 mmol; 84%);
1H NMR (400 MHz, CDCl3) δ1H 7.61 (s, 1H, CH=N), 7.31–7.29 (m, 2H,
ArH), 7.11 (m, 1H, ArH), 3.90–3.88 (apparent t, 4H, CH2O), 3.23–3.21,
(apparent t, 4H, CH2N); 13C NMR (100 MHz, CDCl3) δ13C 134.7, 132.4,
131.3, 129, 128.9, 128, 66.4, 54.4, 51.6.
(E)-1-(4-bromophenyl)-2,2,2-trifluoro-N-morpholinoethan-1-imine
(2c).[21,25,26,37] The compound 2c was prepared according to general
procedure 2 using 1c (135 mg, 0.5 mmol) and the crude product
was purified by column chromatography to afford 2c as a yellow
1
oil. Yield: 121 mg (0.36 mmo; 72%); H NMR (400 MHz, CDCl3) δ1H
7.47 (d, 2H, J=8 Hz), 7.21 (d, 2H, J=8 Hz), 3.53-3.55 (apparent t, 4H,
CH2O), 2.9–2.92 (apparent t, 4H, CH2N); 13C NMR (100 MHz, CDCl3)
2
1
δ13C 135.4 (q, JC-F =34 Hz), 132.3, 130.5, 130.2, 124.4, 122.5 (q, JC-F
=270 Hz), 66.2, 54.4; 19F NMR (376 MHz, CDCl3) δ19F-66.6 (s, 3F); GC-
MS (m/z (relative %)): tR =3.5 min; m/z 338 (M+ +1), 279 (23), 199
(29), 157 (23), 102 (22), 86 (57), 56 (100).
(E)-N-morpholinoheptan-1-imine (1m).[25] The compound 1m was
prepared according to the general procedure using heptanal
(498 mg, 4.36 mmol) and 4-aminomorpholine (891 mg, 8.72 mmol).
1
Yield: 450 mg (2.27 mmol; 52%); H NMR (400 MHz, CDCl3) δ1H 6.93
(s, 1H, CH=N), 3.78–3.77 (apparent t, 4H, CH2O) 2.90–2.92, (apparent
t, 4H, CH2N), 2.20–2.19 (m, 2H, CH2) 1.43–1.25 (m, 8H, 4CH2) 0.84–
0.83 (m, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ13C 142.6, 66.5, 52.6,
33.1, 31.7, 28.9, 27.4, 22.6, 14.1.
(E)-2,2,2-trifluoro-N-morpholino-1-(2-nitrophenyl)ethan-1-imine
(2d).[26] The compound 2d was prepared according to the general
procedure using 1d (133 mg, 0.5 mmol) and the crude product was
purified by column chromatography to afford 2d as a yellow oil.
1
Yield: 108 mg (0.36 mmol; 72%); H NMR (400 MHz, CDCl3) δ1H 8.14
(E)-N-morpholino-1-(3,4,5-trimethoxyphenyl)methanimine (1n)[26] The
compound 1n was prepared according to the general procedure
using 3,4,5- trimethoxybenzaldehyde (521 mg, 2.66 mmol) and 4-
aminomorpholine (542 mg, 5.3 mmol). Yield: 551 mg (1.96 mmol;
(d, 1H, J=8 Hz), 7.68 (d, 1H, J=8 Hz), 7.65–7.7 (m, 1H), 7.62–7.65
(M, 1H), 3.57–3.59 (apparent t, 4H, CH2O), 2.97–2.99 (apparent t, 4H,
2
CH2N); 13C NMR (100 MHz, CDCl3) δ13C 148.2, 134.1, 132.1(q, JC-F
=
33 Hz), 131.7, 127.6, 125.5, 122.6 (q, 1JC-F =280 Hz), 66.6, 54.2; 19F
NMR (376 MHz, CDCl3 ) δ19F À 66.5 (s, 3F); GC-MS (m/z (relative %)):
tR =3.9 min; 303 (4, M+), 203 (6), 123 (38), 43 (100).
1
74%); H NMR (400 MHz, CDCl3) δ1H 7.49 (s, 1H, CH=N), 6.83 (s, 2H,
ArH), 3.88 (s, 9H, 3CH3), 3.88–3.83 (apparent t, 4H, CH2O), 3.16–3.13
(apparent t, 4H, CH2N); 13C NMR (100 MHz, CDCl3) δ13C 153.6, 138.7,
136.3, 131.8, 103.4, 66.6, 61.1, 56.3, 52.1.
(E)-2,2,2-trifluoro-N-morpholino-1-(p-tolyl)ethan-1-imine (2e).[25,26] The
compound 2e was prepared according to general procedure using
1e (110 mg, 0.5 mmol) and the crude product was purified by
column chromatography (3:1 hexane: ethyl acetate) to afford 2e as
a yellow oil. Yield: 92 mg (0.34 mmol; 68%); 1H NMR (400 MHz,
CDCl3); δ1H 7.29 (d, 2H, J=8 Hz), 7.2 (d, 2H, J=8 Hz), 3.59–3.61
(apparent t, 4H, CH2O), 2.95–2.97 (apparent t, 4H, CH2N), 2.36 (s,
3H); 13C NMR (100 MHz, CDCl3) δ13C 130.4, 128.8, 66.6, 54.7 21.9; 19F
NMR (376 MHz, CDCl3 ); δ19F -66.8 (s, 3F); GC-MS (m/z (relative %)):
tR =2.7 min; 272 (100, M.+), 215 (35), 145(40), 118 (42), 86 (47), 56
(71).
Trifluoromethylation of hydrazones
General Procedure (for compounds 2a–2n). An oven-dried round-
bottom flask (25 mL), equipped with a magnetic stir bar, powdered
4 Å mol. sieves, and a N2 balloon, was added Compound 1
(1 mmol), CF3SO2Na (2 mmol), K2S2O8 (3 mmol), and CuSO4.5H2O
(0.5 mmol) at room temperature. A 10 mL portion of acetonitrile
was added to the contents with a syringe under N2. The resulting
°
solution was stirred at 80 C, and the progress of the reaction was
monitored by GC-MS. After the reaction was complete, the reaction
mixture was filtered to remove the molecular sieves, the solvent
was removed in vavuo, and the resulting product was subjected to
column chromatography on silica gel (eluent: 10% ethyl acetate in
hexane) to afford the products 2a–2g. The products were
(E)-1-(4-chlorophenyl)-2,2,2-trifluoro-N-morpholinoethan-1-imine
(2f).[21,26] The compound was prepared according to general
procedure using 1f (24 mg, 0.107 mmol) and the crude product
was purified by column chromatography to afford 2f as a yellow
oil. Yield: 22 mg (0.0752 mmol; 70%); 1H NMR (400 MHz, CDCl3); δ1H
7.38 (m, 4H,ArH), 3.6–3.62 (apparent t, 4H, 2CH2), 2.96–2.99
1
characterized by H NMR, 13C NMR, 19F NMR, and GC-MS, and are in
2
(apparent t, 4H, 2CH2); 13C NMR (100 MHz, CDCl3) δ13C 136.7 (q, JC-F
accordance with literature data. The yields for compounds 2h–2n
were estimated by GC-MS.
1
=36 Hz), 130.4, 129.7, 122.9 (q, JC-F =272 Hz), 66.5, 54.7; 19F NMR
(376 MHz, CDCl3 ) δ19F À 66.8 (s, 3F); GC-MS (m/z (relative %)): tR =
(E)-2,2,2-trifluoro-N-morpholino-1-phenylethan-1-imine
(2a).[21,26,32]
3.0 min; 292 (86, M+.), 235 (32), 165 (37), 138 (44), 86 (55), 56 (100).
The compound 2a was prepared according to general procedure
using 1a (191 mg, 1.0 mmol) and the crude product was purified
by column chromatography to afford 2a as a yellow oil. Yield:
195 mg (0.75 mmol; 75%); 1H NMR (400 MHz, CDCl3) δ1H 7.4 (m, 5H,
ArH), 3.58-3.61 (apparent t, 4H, CH2O), 2.95–2.97 (apparent t, 4H,
(E)-1-(3-bromophenyl)-2,2,2-trifluoro-N-morpholinoethan-1-imine
(2g).[32] The compound 2g was prepared according to general
procedure using 1g (130 mg, 0.48 mmol) and the crude product
was purified by column chromatography to afford 2g as a yellow
2
CH2O); 13C NMR (100 MHz, CDCl3) δ13C 136.6 (q, JC-F =33 Hz), 131.8,
1
oil. Yield: 118 mg (0.35 mmol; 72%); H NMR (400 MHz, CDCl3) δ1H
130, 129, 128.6, 122.7 (q, 1JC-F =280 Hz), 66.5, 54.5; 19F NMR
7.53–7.57 (m, 2H, ArH), 7.28–7.33 (m, 2H, ArH), 3.61-3.63 (apparent t,
Eur. J. Org. Chem. 2021, 2018–2024
2023
© 2021 Wiley-VCH GmbH